High risk of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy presenting with syncope

Robert S Phang1, David Kang, Hocine Tighiouart

  • 1Tufts-New England Medical Center, Boston, Massachusetts, USA. rphang@gmail.com

Insights

Syncope in nonischemic dilated cardiomyopathy (NIDC) indicates high risk, similar to sustained arrhythmias. Patients with NIDC and syncope may benefit from implantable cardioverter-defibrillator (ICD) therapy.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure

Background:

  • Syncope in nonischemic dilated cardiomyopathy (NIDC) prognostic significance is unclear.
  • Randomized controlled implantable cardioverter-defibrillator (ICD) trials often exclude NIDC patients.

Purpose of the Study:

  • Compare outcomes in NIDC patients with syncope versus those with sustained ventricular arrhythmias.
  • Evaluate risk factors for arrhythmias and mortality in NIDC patients.

Main Methods:

  • Retrospective comparison of 108 NIDC patients with syncope and 71 NIDC patients with sustained ventricular arrhythmias.
  • Assessed freedom from ventricular arrhythmias, life-threatening arrhythmias, and all-cause mortality.
  • Follow-up duration: 43.5 ± 32.1 months.

Main Results:

  • No significant difference in outcomes between syncope and arrhythmia groups.
  • Male gender and ICD therapy predicted increased ventricular arrhythmia risk.
  • Reduced ejection fraction and older age predicted increased mortality.

Conclusions:

  • NIDC patients presenting with syncope represent a high-risk population.
  • Event rates in syncope patients are comparable to those with sustained arrhythmias.
  • Consideration for ICD therapy is warranted in NIDC patients with syncope.

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.